AI assistant
GlaxoSmithKline PLC — Director's Dealing 2014
Nov 7, 2014
5262_dirs_2014-11-07_23579ac4-c19b-4250-b871-5f5e46cc3843.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4653W
GlaxoSmithKline PLC
07 November 2014
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc (GSK) was advised on 7 November 2014 of the following increase in the notional allocation of GSK American Depositary Shares (ADSs) on 6 November 2014, at a price of $44.75 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401K plan:
| Director/PDMR | Number of ADSs |
| Mrs D P Connelly | 1 |
| Mr W C Louv | 24 |
| Dr M M Slaoui | 17 |
| Connected person | Number of ADSs |
| Dr K Slaoui (connected person of Dr M M Slaoui) | 16 |
V A Whyte
Company Secretary
7 November 2014
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSFDLFBZFFFFBD